Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-01-01 @ 1:07 PM
Study NCT ID:
NCT00925132
Status:
TERMINATED
Last Update Posted:
2017-07-02
First Post:
2009-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Sponsor:
University of Iowa
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-18
First Submit QC Date:
None
Study First Post Date:
2009-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-15
Results First Submit QC Date:
None
Results First Post Date:
2017-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-05
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL